Improved Centration of the Type 1 Boston Keratoprosthesis in Donor Carrier Tissue

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s12778
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Cost Effectiveness of the Type II Boston Keratoprosthesis

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2010English

Risk of Endophthalmitis in Boston Type 1 Keratoprosthesis Combined With Vitrectomy and Silicone Oil Insertion

Journal of Ophthalmology
Ophthalmology
2019English

Cystoid Macular Edema Following Boston Keratoprosthesis Type II: Treatment

Ophthalmology
Ophthalmology
2019English

Boston Type 1 Keratoprosthesis From Patient Selection Through Postoperative Management: A Review for the Keratoprosthetic Surgeon

Clinical Ophthalmology
Ophthalmology
2016English

Five Year Outcomes of Boston Type I Keratoprosthesis as Primary Versus Secondary Penetrating Corneal Procedure in a Matched Case Control Study

PLoS ONE
Multidisciplinary
2018English

The Altered Renal and Hepatic Expression of Solute Carrier Transporters (SLCs) in Type 1 Diabetic Mice

PLoS ONE
Multidisciplinary
2015English

Improved Carrier Concentration Control in Zn-Doped Ca5Al2Sb6

Journal of Applied Physics
AstronomyPhysics
2011English

Pathological Process of Prompt Connection Between Host and Donor Tissue Vasculature Causing Rapid Perfusion of the Engineered Donor Tissue After Transplantation

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

A New Type of Glycoconjugate Vaccine Containing Klebsiella Fimbriae Type 1 and 3 as Carrier Proteins

Critical Care
Critical CareIntensive Care Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy